Wu Xi App Tec Co., Ltd. Lyell Immunopharma, Inc. Transaction History
Wu Xi App Tec Co., Ltd.
- $19 Billion
- Q3 2024
A detailed history of Wu Xi App Tec Co., Ltd. transactions in Lyell Immunopharma, Inc. stock. As of the latest transaction made, Wu Xi App Tec Co., Ltd. holds 7,390,710 shares of LYEL stock, worth $66.1 Million. This represents 53.56% of its overall portfolio holdings.
Number of Shares
7,390,710
Previous 7,682,156
3.79%
Holding current value
$66.1 Million
Previous $11.1 Billion
8.44%
% of portfolio
53.56%
Previous 47.74%
Shares
3 transactions
Others Institutions Holding LYEL
# of Institutions
117Shares Held
175MCall Options Held
2.9KPut Options Held
6K-
Mwg Management Ltd. Washington, DC20.2MShares$180 Million18.54% of portfolio
-
Foresite Capital Management Iv, LLC Larkspur, CA16MShares$143 Million9.84% of portfolio
-
Apoletto LTD Washington, DC15.1MShares$135 Million42.56% of portfolio
-
Orland Properties LTD Washington, DC15.1MShares$135 Million9.84% of portfolio
-
Black Rock Inc. New York, NY13.5MShares$121 Million0.0% of portfolio
About Lyell Immunopharma, Inc.
- Ticker LYEL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 247,824,992
- Market Cap $2.22B
- Description
- Lyell Immunopharma, Inc., a T cell reprogramming company, engages in developing T cell therapies for patients with solid tumors. The company develops therapies using technology platforms, such as Gen-R, an ex vivo genetic reprogramming technology to overcome T cell exhaustion; and Epi-R, an ex vivo epigenetic reprogramming technology to generate...